- 专利标题： DIAZABICYCLIC SUBSTITUTED IMIDAZOPYRIMIDINES AND THEIR USE FOR THE TREATMENT OF BREATHING DISORDERS
-
申请号： US17305927申请日： 2021-07-16
-
公开(公告)号： US20220017540A1公开(公告)日： 2022-01-20
- 发明人: Martina DELBECK , Michael HAHN , Thomas MÜLLER , Klemens LUSTIG , Karl COLLINS , Niels LINDNER , Janine NICOLAI , Moritz BECK-BROICHSITTER , Udo ALBUS , Doris GEHRING , Björn ROSENSTEIN
- 申请人： Bayer Aktiengesellschaft , Bayer Pharma Aktiengesellschaft
- 申请人地址： DE Leverkusen; DE Berlin
- 专利权人： Bayer Aktiengesellschaft,Bayer Pharma Aktiengesellschaft
- 当前专利权人： Bayer Aktiengesellschaft,Bayer Pharma Aktiengesellschaft
- 当前专利权人地址： DE Leverkusen; DE Berlin
- 优先权： EP17176046.5 20170614,EP17193252.8 20170926
- 主分类号： C07D519/00
- IPC分类号： C07D519/00 ; A61P11/00
摘要：
The present invention relates to novel diazabicyclically substituted imidazo[1,2-a]pyrimidine derivatives, to methods for producing the same, to the use thereof either alone or in combinations for the treatment and/or prevention of diseases, as well as to their use for preparing medicaments for the treatment and/or prevention of diseases, especially for treatment and/or prevention of breathing disorders, including sleep-related breathing disorders such as obstructive and central sleep apnoea and snoring.
信息查询
